Incidence of acute pancreatitis and nucleoside reverse transcriptase inhibitors usage

International Journal of STD and AIDS

Volumn 16, Issue 6, 2005, Pages 427-429

  Dragovic, G ^a   Milk, N ^a   Jevtovic, D J ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Acute pancreatitis; Didanosine; Nucleoside reverse transcriptase inhibitors; Stavudine

Indexed keywords

DIDANOSINE; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; ANOREXIA; ARTICLE; CONFIDENCE INTERVAL; DIARRHEA; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VOMITING;

EID: 20944442696     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462054094042     Document Type: Article

References (8)

1. Bush ZM, Kosminski LA. Acute pancreatitis in HIV-infected patients: are etiologies changing since the introduction of protease inhibitor therapy. Pancreas 2003;27:1-5
2. Rossero R, Asmuth DM, Grady JJ, et al. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature. Int J STD AIDS 2003;14: 350-5
3. Moore RD, Keruly JC, Chaison RE. Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs. AIDS 2001;15:617-20
4. Dragovic G, Jevtovic DJ. Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients. Antiviral Chem Chemother 2003;14:281-4
5. Gan I, May G, Raboud J, et al. Pancreatitis in HIV infection: predictors of severity. Am J Gastroenterol 2003;98: 1278-83
6. Barreiro P, Soriano V, Valencia E, et al. Low risk of pancreatitis in HIV-infected patients on hydroxyurea plus didanosine. AIDS 2001;15:2469-70
7. Frippiat F, Derue G, Heller F, et al. Acute pancreatitis associated with severe lactic acidosis in human immunodeficiency virus-infected patients receiving triple therapy. J Antimicrob Chemother 2000;45:411-12
8. Cote H, Brumme Z, Craib K, et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002;346:811-20